TEVOGEN INC (TVGN:NASDAQ)
$7.05 0.33 (4.9107%)
Analysed TEVOGEN INC (TVGN:NASDAQ) News Sources
Tevogen Advances Strategic CRO Evaluation to Expand Clinical Research Delivery Capabilities and Drive Revenue Growth
26-03-2026
yahoo.com
Tevogen.AI Nears Completion of PredicTcell™ Training; Initiates Commercial Readiness and Debuts Internal Application Portal
27-04-2026
yahoo.com
Tevogen (TVGN) Soars 11% as Firm Gears Up for AI Training Commercialization
05-05-2026
yahoo.com
Tevogen Announces $3 Million Private Investment at $8 Per Share, a 14% Premium from Latest Market Close
12-05-2026
yahoo.com
Letter to Shareholders from CEO Dr. Ryan Saadi
18-05-2026
yahoo.com
Tevogen Signs Letter of Intent to Evaluate Potential Acquisition of a Management Services Organization
21-05-2026
yahoo.com
Tevogen Advances Strategic Acquisition Initiatives with Potential to Support Approximately $100 Million in Combined Annual Revenue
28-05-2026
yahoo.com
Tevogen Announces Formation of a Healthcare Services Initiative
09-06-2026
yahoo.com
Tevogen Bio Announces 2026 Annual Meeting of Stockholders
14-07-2026
yahoo.com
Tevogen Bio Holdings Inc. Becomes Tevogen Inc.
29-07-2026
yahoo.com
What is the current price of TEVOGEN INC (TVGN:NASDAQ)?
The current price of TEVOGEN INC (TVGN:NASDAQ) is $7.05.
TEVOGEN INC (TVGN:NASDAQ) absolute price change since previous trading day?
The absolute price change of TEVOGEN INC (TVGN:NASDAQ) since the previous trading day is $0.33.
TEVOGEN INC (TVGN:NASDAQ) percentage price change since previous trading day?
The percentage price change of TEVOGEN INC (TVGN:NASDAQ) since the previous trading day is 4.9107%.
What is the most recent average sentiment score for TEVOGEN INC (TVGN:NASDAQ)?
The most recent average sentiment score for TEVOGEN INC (TVGN:NASDAQ) is 78 out of 100.
What is the most recent average sentiment for TEVOGEN INC (TVGN:NASDAQ)?
The most recent sentiment for TEVOGEN INC (TVGN:NASDAQ) is .
SEC-8K** Filing Available For TEVOGEN INC (TVGN:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.